Bausch Health Companies (BHC) Accumulated Expenses (2009 - 2026)
Bausch Health Companies (BHC) posted Accumulated Expenses of $3.1 billion for Q2 2026, up 1.09% sequentially from $3.0 billion in Q1 2026, and down 11.5% YoY from $3.5 billion in Q2 2025.
Bausch Health Companies (BHC) Accumulated Expenses (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Accumulated Expenses for 18 years, with the latest figure at $3.1 billion in Q2 2026.
- Quarterly Accumulated Expenses fell 11.5% year-over-year to $3.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.1 billion (down 11.5% YoY) and the FY2025 annual result came in at $3.3 billion, down 4.16% from the prior year.
- Accumulated Expenses rose to $3.1 billion in Q2 2026 per BHC's latest filing, from $3.0 billion in the prior quarter.
- Over five years, Accumulated Expenses peaked at $4.3 billion in Q2 2022 and troughed at $2.9 billion in Q1 2023.
- A 5-year average of $3.3 billion and a median of $3.3 billion in 2024 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2024: Accumulated Expenses slumped 41.11% in 2022, then advanced 11.36% in 2024.
- Over 5 years, Accumulated Expenses stood at $3.0 billion in 2022, then advanced by 4.85% to $3.1 billion in 2023, then gained by 11.36% to $3.5 billion in 2024, then decreased by 4.16% to $3.3 billion in 2025, then fell by 8.19% to $3.1 billion in 2026.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $3.1 billion, $3.0 billion, and $3.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Bausch Health Companies | 2.42 Bn | 586.38 Mn | 2.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.07 Bn |
| Mar 31, 2026 | 3.04 Bn |
| Dec 31, 2025 | 3.34 Bn |
| Sep 30, 2025 | 3.60 Bn |
| Jun 30, 2025 | 3.47 Bn |
| Mar 31, 2025 | 3.35 Bn |
| Dec 31, 2024 | 3.49 Bn |
| Sep 30, 2024 | 3.39 Bn |
| Jun 30, 2024 | 3.34 Bn |
| Mar 31, 2024 | 3.23 Bn |
| Dec 31, 2023 | 3.13 Bn |
| Sep 30, 2023 | 3.12 Bn |
| Jun 30, 2023 | 3.01 Bn |
| Mar 31, 2023 | 2.92 Bn |
| Dec 31, 2022 | 2.99 Bn |
| Sep 30, 2022 | 2.93 Bn |
| Jun 30, 2022 | 4.31 Bn |
| Mar 31, 2022 | 4.30 Bn |
| Dec 31, 2021 | 4.79 Bn |
| Sep 30, 2021 | 4.98 Bn |